Neonatal Total Body Cooling Device for Treating Hypoxic-Ischemic Encephalopathy
The Neonatal Cooling device is used to reduce and treat brain injuries and neurological dysfunctions caused by asphyxia in newborns. Term infants with hypoxic-ischemic encephalopathy (HIE) are at risk of mild to severe neurodevelopmental deficits. Alongside supportive drug treatments, neonatal cooling is recognized as the only effective intervention to reduce the severity of these complications.
This device includes a main unit that cools a water-based fluid, which then circulates through specially designed caps, mattresses, or blankets. The standard treatment protocol requires that therapy begins within the window from birth to a maximum of 6 hours after birth. The core temperature is gradually lowered to a range of 33.5 ± 0.5°C. The temperature is then maintained within this range for 72 hours, followed by a gradual rewarming to normal body temperature.
The high precision required in cooling and rewarming scenarios and the high reliability needed for long-term operation are key features of this device.
